Search


How NYSE is investing in the biotech sector
Head of Healthcare & Life Sciences Capital Markets Johanna Grossman describes the assets that NYSE has available for biotech companies that
Jan 22, 2024
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.